IQVIA SOLUTIONS ASIA PTE. LTD.
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Computer Processing and Data Preparation and Processing Services, Information Retrieval Services), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about IQVIA SOLUTIONS ASIA PTE. LTD.
Live alerts from global media, monitored by Business Radar
2025-01-29 (marketbeat.com)
Smith Group Asset Management LLC Acquires New Holdings in IQVIA Holdings Inc. (NYSE:IQV)
Smith Group Asset Management LLC acquired a new stake in IQVIA Holdings Inc. (NYSE:IQV - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 8,224 shares of the medical research company's stock, valued at app
Read more
2025-01-23 (stocknews.com)
NVDA: 3 Semiconductor Innovators Powering Tomorrow’s Technologies |
NVIDIA Corporation(NASDAQ:NVDA): From cutting-edge AI chips to energy-efficient solutions, semiconductor stocks are driving innovation across industries. Amid this backdrop, it could be wise for investors to add NVIDIA Corp (NVDA), Broadcom (AVGO), and QUALCOMM (QCOM) to their watchlists. Read more…
Read more
2024-10-04 (marketbeat.com)
4,864 Shares in IQVIA Holdings Inc. (NYSE:IQV) Acquired by Mattson Financial Services LLC
Mattson Financial Services LLC bought a new stake in IQVIA Holdings Inc. (NYSE:IQV - Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 4,864 shares of the medical research company's stock, value
Read more
2024-01-02 (investopedia.com)
3 Charts For Investors to Watch Tuesday: IQVIA Holdings, BGC Group, WGMI ETF
These two stocks and one ETF are worth monitoring today. We discuss why and identify important chart levels to watch.
Read more
2012-02-18 (apotheke-adhoc.de)
The powerful minority shareholder
Financial investors have no place in the pharmacy market thanks to the ban on third-party ownership and multiple ownership. The situation is different in the field of parenteral formulations - here industrial manufacturing companies are increasingly competing with cytopharmacies.
Read more